Highlights

  • Pro Medicus reported record FY2026 Revenue and underlying Earnings growth.
  • The company continued expanding adoption of its Visage medical imaging platform.
  • North America remained the largest contributor to revenue during the period.
  • Forward contracted revenue increased as new agreements and renewals were secured.
  • Future updates will focus on customer implementations, product development and market expansion.

Pro Medicus Limited (ASX:PME) is a healthcare technology company providing medical imaging software solutions to hospitals and imaging groups. Its Visage platform enables the viewing and management of medical images through cloud-based technology. During FY2026, the company continued expanding its customer base while progressing product development and commercial opportunities.

FY2026 Financial Performance

Pro Medicus reported revenue of A$261.7 million for FY2026, representing growth compared with the previous year. Underlying net profit after tax was A$144.7 million, supported by continued Demand for the company’s medical imaging software solutions. The company also reported strong underlying margins during the period.

Visage Imaging Platform

The company’s core product is the Visage platform, a cloud-native medical imaging solution used by healthcare organisations. Revenue is generated through long-term customer contracts and transaction-based arrangements linked to imaging activity. Growth depends on new customer implementations, usage volumes and contract renewals.

Regional Performance

North America remained the largest contributor to Pro Medicus’ revenue during FY2026. The company continues targeting healthcare organisations in the United States market, while maintaining operations across Australia and Europe.

Contract Pipeline and Customer Growth

Pro Medicus reported new contracts, renewals and additions during FY2026, supporting a growing forward contracted revenue base. Large healthcare agreements require implementation periods before revenue is fully recognised, making successful customer deployment an important operational milestone.

Product Development and Innovation

The company continues developing additional imaging capabilities, including modules designed for broader clinical applications. Product innovation remains focused on improving healthcare workflows and supporting future customer requirements.

Financial Position

Pro Medicus reported cash holdings of A$216.1 million and no borrowings during FY2026. The company maintained strong cash conversion, supporting continued Investment in technology development and Business operations.

Industry Environment and Risks

Healthcare software providers operate in a competitive technology environment where hospitals consider reliability, integration capability and long-term support when selecting platforms. Key considerations include customer adoption, implementation timing, regulatory requirements and technology development.

Future Areas to Monitor

Future updates may provide information on new contracts, customer go-lives, platform developments and international expansion. The company’s ability to convert contracted opportunities into Recurring Revenue will remain an important area of focus.

Key Insights

Pro Medicus’ FY2026 performance highlights a healthcare technology business supported by cloud imaging adoption and long-term customer relationships. The company continues expanding its platform while maintaining strong financial metrics. Future progress will depend on customer growth, product innovation and successful execution of implementation programmes.